BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 27
• 30
• 31

• GlaxoSmithKline Pumps $330 Million More Into Manufacturing

  December 11, 2013

   · 

  1 min read
• Drug Development

  AVANIR Pharmaceuticals Crashes As Multiple Sclerosis Drug Fails Phase 2 Trial

  December 11, 2013

   · 

  4 min read
• Deals

  Savient Pharmaceuticals, Inc. Agrees To Unload All Assets To Crealta Pharmaceuticals For $120.4 Million

  December 11, 2013

   · 

  10 min read
• BioMidwest

  St. Jude Medical Halts Enlightn IV Trial

  December 11, 2013

   · 

  1 min read
• Deals

  Karyopharm Therapeutics Announces Full Exercise Of Underwriters’ Option To Purchase Additional Shares In Its Initial Public Offering

  December 11, 2013

   · 

  1 min read
• Pharm Country

  NanoViricides, Inc. Announces That Its Annual Meeting Was Held On December 9th, 2013; the CEO Presentation Is Available On The Redesigned Website

  December 11, 2013

   · 

  1 min read
• Policy

  NovaBay Pharmaceuticals, Inc. Gains ISO 13485 Certification For The Design And Manufacturing Of Neutrophase®

  December 11, 2013

   · 

  1 min read
• Business

  VeriTeQ Corporation To Commercially Launch Q Inside Safety Technology In The First Quarter Of 2014

  December 11, 2013

   · 

  1 min read
• Drug Development

  Kamada Ltd. Announces Completion Of Pivotal Phase 2/3 Clinical Trial In Europe And Canada Of Inhaled AAT To Treat Alpha-1 Antitrypsin Deficiency

  December 11, 2013

   · 

  1 min read
• Drug Development

  Pharmacyclics, Inc. Announces Data Presentations For Ibrutinib In B-Cell Malignancies

  December 11, 2013

   · 

  21 min read